Table 3a.
Multivariate logistic regression analysis of predictors for positive IgG antibodies following the second dose of vaccine in immunocompromised patients (1002) and immunocompetent controls (272); N = 1274.
| Effect | Odds ratio | Lower 95% CI | Upper 95% CI | P-value |
|---|---|---|---|---|
| Gender, F vs. M | 1.23 | 0.89 | 1.69 | 0.21 |
| Age, > 65 y vs. < 65y | 0.41 | 0.30 | 0.57 | < 0.0001 |
| Days after 2nd vaccine | 1.02 | 1.01 | 1.04 | 0.0064 |
| HIV | 0.80 | 0.13 | 4.90 | 0.81 |
| Solid malignancies | 0.08 | 0.02 | 0.27 | < 0.0001 |
| Multiple myeloma | 0.06 | 0.02 | 0.19 | < 0.0001 |
| HSCT | 0.04 | 0.01 | 0.13 | < 0.0001 |
| Liver transplant | 0.03 | 0.01 | 0.12 | < 0.0001 |
| Myelodysplastic disorders | 0.02 | 0.01 | 0.08 | < 0.0001 |
| CLL/NHL | 0.02 | 0.00 | 0.05 | < 0.0001 |
| Kidney transplant | 0.01 | 0.00 | 0.03 | < 0.0001 |
| Heart transplant | 0.00 | 0.00 | 0.01 | < 0.0001 |